En 6 día(s), 18 hora(s) y 31 minuto(s): El Repositorio Institucional UNAL informa a la comunidad universitaria que, con motivo del periodo de vacaciones colectivas, el servicio de publicación estará suspendido: Periodo de cierre: Del 20 de diciembre al 18 de enero de 2026. Sobre los depósitos: Durante este tiempo, los usuarios podrán continuar realizando el depósito respectivo de sus trabajos en la plataforma. Reanudación: Una vez reiniciadas las actividades administrativas, los documentos serán revisados y publicados en orden de llegada.

¿Qué factores contribuyen a la aceptación de un método anticonceptivo posterior a una Interrupción Voluntaria del embarazo en una institución privada del país?

dc.contributor.advisorGómez, Pio Ivánspa
dc.contributor.authorHinojosa-Millán, Saloméspa
dc.contributor.authorFoliaco-Calderón, Nataliaspa
dc.contributor.researchgroupSALUD SEXUAL Y REPRODUCTIVAspa
dc.coverage.sucursalUniversidad Nacional de Colombia - Sede Bogotáspa
dc.date.accessioned2020-01-20T14:52:58Zspa
dc.date.available2020-01-20T14:52:58Zspa
dc.date.issued2020-01-20spa
dc.date.issued2020-01-20spa
dc.description.abstractObjective: assess the factors that influence contraceptive uptake among patients who undergo a voluntary termination of pregnancy in a private institution. Methods: Descriptive observational study, cohort type. Post-abortion contraception described as any contraception method provided during the first four weeks of the induced abortion. Prospective gathering of information supplied by clinical records and dispensary data. Inclusion criteria: women who interrupted their pregnancy voluntarily from 1st of January 2018 through 31ST of December 2018. Exclusion criteria: Women with cognitive deficit and incomplete data. Adjusted analysis was performed. Results: The total of patients included in the study were 5424. 90% of women left the facility with a contraceptive method. The majority (47.1%) selected a short-acting method. Women between 20 to 29 years old were more likely to choose a method than women 30 years or older (adjusted odds ratio [OR], 1.24; 95% confidence interval [CI], 1.01 – 1.5). Young women were also significantly more likely to choose a long-acting, reversible contraceptive than those ages 30 years or older (19 years: OR, 1.73; 95% CI, 1.4 to 2.4; 20–29 years: OR, 1.2; 95% CI, 1.1 to 1.5). Also, women with 18 weeks of pregnancy or longer (OR, 1.69; 95% CI, 1.08 to 2.6) and those who had a surgical abortion (OR, 1.5; 95% CI, 1.3 to 1.8). Conclusion: The majority of patients accepted a post abortion contraceptive method, mainly short-acting methods. Being between 20 and 29 years old was associated with accepting any type of contraception, the use of long-term contraceptives was associated with surgical abortion.spa
dc.description.abstractObjetivo: Evaluar factores que influyen en el inicio de un método anticonceptivo posterior a una interrupción voluntaria del embarazo en una clínica privada de Bogotá. Métodos: Estudio descriptivo observacional, tipo cohorte. Anticoncepción postaborto definida como la suministrada dentro de las 4 semanas posteriores al aborto. Recolección prospectiva de información, mediante historia clínica y datos del dispensario. Criterios de inclusión: Mujeres en quienes se realizó una interrupción voluntaria de embarazo entre 1 enero de 2018 y 31 de diciembre de 2018. Criterios de exclusión: Mujeres con déficit cognoscitivo y datos incompletos. Se realizó análisis ajustado. Resultados: Se incluyeron 5424 pacientes, 90% aceptó algún método anticonceptivo. La mayoría (47,1%) seleccionaron un método de acción corta. Las mujeres entre 20 a 29 años tenían más probabilidades de elegir un método anticonceptivo en comparación con las mayores de 30 años (odds ratio ajustado [aOR] 1.24; intervalo de confianza [IC] del 95%, (1.01 – 1.5)). Las mujeres menores de 30 años fueron más propensas a elegir un anticonceptivo de acción prolongada (≤19 años: OR 1.73; IC del 95%, (1.4-2.4); 20-29 años: OR, 1.3; IC 95%, (1.1 -1.5), también las mujeres con embarazos mayores a 18 semanas (OR 1.69; [IC] del 95%, (1,08 – 2.6) y con aborto quirúrgico (OR 1.5; [IC] del 95%, (1.3 – 1.8). Conclusión: La mayoría aceptó algún método de anticonceptivo postaborto, principalmente métodos de corta acción. Tener entre 20 y 29 años se asoció al uso de algún tipo de anticoncepción, el uso de anticonceptivos de larga duración se asoció al aborto quirúrgico.spa
dc.format.extent56spa
dc.format.mimetypeapplication/pdfspa
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/75496
dc.language.isospaspa
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotáspa
dc.relation.references1. Gómez I, Urquijo L, Villarreal C. Estrategia FIGO para la prevención del aborto inseguro, experiencia en Colombia. Rev Colomb Obstet y Ginecol. 2011;62(1):24–35.spa
dc.relation.references2. Corte Constitucional de Colombia. Sentencia C-355 de 2006. Bogotá. 2006. Available from: http://www.alcaldiabogota.gov.co/sisjur/normas/Norma1.jsp?i=21540spa
dc.relation.references3. Samuel M, Fetters T, Desta D. Strengthening Postabortion Family Planning Services in Ethiopia: Expanding Contraceptive Choice and Improving Access to Long-Acting Reversible Contraception. Glob Heal Sci Pract. The Johns Hopkins Bloomberg School of Public Health Center for Communication Programs. 2016;4 (Suppl 2):S60-72.spa
dc.relation.references4. MINISTERIO DE SALUD Y PROTECCIÓN SOCIAL. Atención Post Aborto (APA) y sus complicaciones. Bogotá. 2014.spa
dc.relation.references5. Marrs RP, Kletzky OA, Howard WF, Mishell DR. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion. Am J Obstet Gynecol. Mosby; 1979;135(6):731–6.spa
dc.relation.references6. Schreiber CA, Sober S, Ratcliffe S, Creinin MD. Ovulation resumption after medical abortion with mifepristone and misoprostol. Contraception. 2011;84(3):230–3.spa
dc.relation.references7. World Health Organization. Safe abortion: technical and policy guidance for health systems Second edition technical and policy guidance for health systems. 2012. Available from: www.who.int/reproductivehealthspa
dc.relation.references8. Bitzer J, Gemzell-Danielsson K, Roumen F, Marintcheva-Petrova M, van Bakel B, Oddens BJ. The CHOICE study: Effect of counselling on the selection of combined hormonal contraceptive methods in 11 countries. Eur J Contracept Reprod Heal Care. 2012;17(1):65–78.spa
dc.relation.references9. Goodman S, Hendlish SK, Reeves MF, Foster-Rosales A. Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion. Contraception. 2008;78(2):143–8.spa
dc.relation.references10. Rose SB, Lawton BA. Impact of long-acting reversible contraception on return for repeat abortion. Am J Obstet Gynecol. 2012;206(1):37.e1-37.e6.spa
dc.relation.references11. Reeves MF, Smith KJ, Creinin MD. Contraceptive Effectiveness of Immediate Compared With Delayed Insertion of Intrauterine Devices After Abortion. Obstet Gynecol. 2007;109(6):1286–94.spa
dc.relation.references12. Salcedo J, Sorensen A, Rodriguez MI. Cost analysis of immediate postabortal IUD insertion compared to planned IUD insertion at the time of abortion follow up. Contraception. 2013 ;87(4):404–8.spa
dc.relation.references13. Vayssière C, Gaudineau A, Attali L, Bettahar K, Eyraud S, Faucher P, et al. Elective abortion: Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol Reprod Biol. 2018;222:95–101.spa
dc.relation.references14. Huber D, Curtis C, Irani L, Pappa S, Arrington L. Postabortion Care: 20 Years of Strong Evidence on Emergency Treatment, Family Planning, and Other Programming Components. Glob Heal Sci Pract. Global Health: Science and Practice; 2016;4(3):481–94.spa
dc.relation.references15. Alemayehu T, Hendrickson C, Brahmi D, Desta D, Fetters T. An evaluation of postabortion contraceptive uptake following a youth-friendly service intervention in Ethiopia. Contraception. 2013;88(3):447–8.spa
dc.relation.references16. Foundation LU and B& MG. London Summit on Family Planning. Summ commitments. 2012.spa
dc.relation.references17. Prada E, MaddowZimet I, Fátima Y, Juárez. El costo de la atención postaborto y del aborto legal en Colombia. Perspect Int en Salud Sex y Reprod. 2014;2–12.spa
dc.relation.references18. Benson J, Andersen K, Healy J, Brahmi D. What Factors Contribute to Postabortion Contraceptive Uptake By Young Women? A Program Evaluation in 10 Countries in Asia and sub-Saharan Africa. Glob Heal Sci Pract. The Johns Hopkins Bloomberg School of Public Health Center for Communication Programs; 2017;5(4):644–57.spa
dc.relation.references19. Ministerio de Salud y Protección Social. Profamilia. Encuesta Nacional de Demografía y Salud. Situación los Niños y Niñas en Colomb. 2016;430.spa
dc.relation.references20. Amado ED, Calderón García MC, Cristancho KR, Salas EP, Hauzeur EB. Obstacles and challenges following the partial decriminalisation of abortion in Colombia. Reprod Health Matters. 2010;18(36):118–26.spa
dc.relation.references21. Prada E, Singh S, Remez L, Villarreal C. Embarazo no deseado y aborto inducido en Colombia: causas y consecuencias. Nueva York Guttmacher Institute. 2011. Available from: https://www.guttmacher.org/sites/default/files/report_pdf/embarazo-no-deseado-colombia_1.pdfspa
dc.relation.references22. Laursen L, Stumbras K, Lewnard I, Haider S. Contraceptive Provision after Medication and Surgical Abortion. Women’s Heal Issues. 2017;27(5):546–50.spa
dc.relation.references23. Profamilia. Informe Anual de Actividadades 2017. Colombia; 2017.spa
dc.relation.references24. High Impact Practices in Family Planning (HIP). Postabortion family planning: a critical component of postabortion care. Washington, DC: USAID; 2019. Available from: https://www.fphighimpactpractices.org/briefs/postabortion-family-planning/spa
dc.relation.references25. Teen Abortions - Child Trends. 2018. Available from: https://www.childtrends.org/indicators/teen-abortionsspa
dc.relation.references26. Sedgh G, Bankole A, Singh S, Eilers M. Legal Abortion Levels and Trends By Woman’s Age at Termination. Int Perspect Sex Reprod Health. 2012;38(3):143–53.spa
dc.relation.references27. Aborto sin riesgos: guía técnica y de políticas para sistemas de salud – 2ª ed. Organización Mundial de la Salud, 2012.spa
dc.relation.references28. CONGRESO DE LA REPÚBLICA. Ley 1090 de 2006. Colombia. 2006. Available from: https://www.funcionpublica.gov.co/eva/gestornormativo/norma.php?i=66205spa
dc.relation.references29. Biney AAE, Atiglo DY. Examining the association between motivations for induced abortion and method safety among women in Ghana. Women Health. 2017;57(9):1044–60.spa
dc.relation.references30. Singh N, Shukla S. Does violence affect the use of contraception? Identifying the hidden factors from rural India. J Fam Med Prim Care. Medknow; 2017;6(1):73.spa
dc.relation.references31. Insurance Coverage of Contraceptives. Guttmacher Institute. 2019. Available from: https://www.guttmacher.org/state-policy/explore/insurance-coverage-contraceptivesspa
dc.relation.references32. Benson J, Andersen K, Healy J, Brahmi D. What Factors Contribute to Postabortion Contraceptive Uptake By Young Women? A Program Evaluation in 10 Countries in Asia and sub-Saharan Africa. Glob Heal Sci Pract. 2017;5(4):644–57.spa
dc.relation.references33. Rivas AT. Prevenir y educar: sobre la historia de la educación sexual en Colombia. Praxis & Saber. 2017; 8 (17).spa
dc.relation.references34. Ezeh AC. The influence of spouses over each other’s contraceptive attitudes in Ghana. Stud Fam Plann. 1993;24(3):163–74.spa
dc.relation.references35. Benson J, Andersen K, Brahmi D, Healy J, Mark A, Ajode A, et al. Global Public Health An International Journal for Research, Policy and Practice What contraception do women use after abortion? An analysis of 319,385 cases from eight countries. Public Health. 2016;13(1):35–50.spa
dc.relation.references36. Benson J, Andersen K, Brahmi D, Healy J, Mark A, Ajode A, et al. What contraception do women use after abortion? An analysis of 319,385 cases from eight countries. Glob Public Health. 2018;13(1):35–50.spa
dc.relation.references37. Goyal V, Canfield C, Aiken ARA, Dermish A, Potter JE. Postabortion Contraceptive Use and Continuation When Long-Acting Reversible Contraception Is Free. Obstet Gynecol. 2017;129(4):655–62.spa
dc.rightsDerechos reservados - Universidad Nacional de Colombiaspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.licenseAtribución-NoComercial 4.0 Internacionalspa
dc.rights.spaAcceso abiertospa
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/spa
dc.subject.ddcMedicina y salud::Ginecología, obstetricia, pediatría, geriatríaspa
dc.subject.proposalAborto inducido, Anticoncepción, Anticoncepción Reversible de Larga Duraciónspa
dc.subject.proposalAbortion, Induced, Contraception, Long-Acting Reversible Contraception.eng
dc.title¿Qué factores contribuyen a la aceptación de un método anticonceptivo posterior a una Interrupción Voluntaria del embarazo en una institución privada del país?spa
dc.title.alternativeWhat factors contribute to the acceptance of a method contraceptive after a Voluntary Interruption of pregnancy in a private institution ?spa
dc.typeTrabajo de grado - Especialidad Médicaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdccspa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/masterThesisspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2spa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
1088299520.2020.pdf
Tamaño:
543.57 KB
Formato:
Adobe Portable Document Format

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
3.9 KB
Formato:
Item-specific license agreed upon to submission
Descripción: